Vitamin D deficiency: concern for rheumatoid arthritis and COVID-19?

8Citations
Citations of this article
78Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Vitamin D is an immunomodulatory hormone with an established role in calcium and phosphate metabolism and skeletal mineralization. Evidence showing its immunological benefits by regulating essential components of the innate and adaptive immune system is prevalent. Vitamin D deficiency is reported worldwide and is thereby found to be associated with various immune-related diseases. Rheumatoid Arthritis and COVID-19 are two such diseases, sharing a similar hyperinflammatory response. Various studies have found an association of lower Vitamin D levels to be associated with both these diseases. However, contrasting data is also reported. We review here the available scientific data on risk factor association and supplementation benefits of Vitamin D in Rheumatoid Arthritis and COVID-19, intending to critically evaluate the literature.

Cite

CITATION STYLE

APA

Verma, S., Chaturvedi, V., Ganguly, N. K., & Mittal, S. A. (2021, December 1). Vitamin D deficiency: concern for rheumatoid arthritis and COVID-19? Molecular and Cellular Biochemistry. Springer. https://doi.org/10.1007/s11010-021-04245-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free